Affordable Access

Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.

Authors
  • Hodis, Howard N
  • Mack, Wendy J
  • Zheng, Ling
  • Li, Yanjie
  • Torres, Mina
  • Sevilla, Diego
  • Stewart, Yolanda
  • Hollen, Barbara
  • Garcia, Karla
  • Alaupovic, Petar
  • Buchanan, Thomas A
Type
Published Article
Journal
Diabetes Care
Publisher
American Diabetes Association
Publication Date
Jul 01, 2006
Volume
29
Issue
7
Pages
1545–1553
Identifiers
PMID: 16801577
Source
Medline
License
Unknown

Abstract

Insulin sensitization and reduction in blood pressure may be contributory mechanisms by which troglitazone reduced subclinical atherosclerosis progression in this cohort of well-controlled insulin-dependent patients with clinical characteristics suggesting type 2 diabetes.

Report this publication

Statistics

Seen <100 times